Scientific and Standardization Committee Communications
Schattauer GmbH
Platelets and Phospholipids in Tissue Factor-initiated Thrombin Generation
Saulius Butenas
1
University of Vermont, Departments of Biochemistry and Medicine, Burlington, Vermont, USA
,
Richard F Branda
1
University of Vermont, Departments of Biochemistry and Medicine, Burlington, Vermont, USA
,
Cornelis van ’t Veer
1
University of Vermont, Departments of Biochemistry and Medicine, Burlington, Vermont, USA
,
Kevin M Cawthern
1
University of Vermont, Departments of Biochemistry and Medicine, Burlington, Vermont, USA
,
Kenneth G Mann
1
University of Vermont, Departments of Biochemistry and Medicine, Burlington, Vermont, USA
› InstitutsangabenThis study was supported by Program Project Grant HL 46703 from the National Institutes of Health (KGM) and by a TALENT stipend of the Netherlands Organization of Scientific Research (CvV).
The influence of platelets on tissue factor (TF)-initiated thrombin generation in a reconstituted model of blood coagulation and in whole blood was evaluated. No thrombin generation was observed over 15 min in the reconstituted model when either TF or platelets and phospholipids were omitted. At 25 pM TF, the rates of thrombin generation were platelet and PCPS concentration-dependent and achieved maximum (1.0 nM/s) in the physiological range of platelet concentration. Similar rates were achieved in the absence of platelets when 1-2 μM phospholipid was used. However, the maximum rates of thrombin generation (5.2-6.0 nM/s) and the shortest initiation phase (1 min) were attained between 25 and 100 μM phospholipid. In the reconstituted model, an increase in platelet concentration from 0.125 × 108/ml to 0.5 × 108/ml decreased the duration of the initiation phase (in the absence of phospholipids) from 4.3 min to 2 min. Further increases in platelet concentration did not affect this phase. Sequential whole blood studies were conducted in blood of a chemotherapy patient who developed reduced platelet counts. The TF (12.5 pM) initiated clotting of patient’s blood was accelerated from ~10 min to 5 min when the platelet concentration increased from 0.05 × 108/ml to 0.11 × 108/ml. Clotting times were essentially unchanged for platelet concentrations exceeding 0.5 × 108/ml (range 0.5-3.1 × 108/ml). Similarly, clotting of whole blood obtained from healthy volunteers was not affected by the platelet count, which varied from 1.5 × 108/ml to 3.1 × 108/ml (4.0 ± 0.5 min). The data obtained in both models are consistent with in vivo observations that clinical bleeding is most likely to occur at platelet counts <0.1 × 108/ml.
Portions of this work were presented at the 40th Annual Meeting of the American Society of Hematology, December 4-8, 1998, Miami Beach, Florida (abstracts #140 and #738).
1
Jenny NS,
Mann KG.
Coagulation cascade: an overview. In:
Loscalzo J,
Schafer AI.
eds.
Throm Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: 3-27.
2
Bevers EM,
Comfinius P,
van Rijn JLML,
Hemker HC,
Zwaal RFA.
Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
3
Rosing J,
van Rijn JLML,
Bevers EM,
van Dieijen G,
Comfurius P,
Zwaal RF.
The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-32.
5
Pieters J,
Lindhout T,
Hemker HC.
In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-4.
6
Butenas S,
van ’t Veer C,
Mann KG.
Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272: 21527-33.
12
Tracy PB,
Eide LL,
Mann KG.
Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
16
Krishnaswamy S,
Field KA,
Edgington TS,
Morrissey JH,
Mann KG.
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 1992; 267: 26110-20.
17
Neuenschwander PF,
Morrissey JH.
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem 1994; 269: 8007-13.
21
Lawson JH,
Kalafatis M,
Stram S,
Mann KG.
A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 1994; 269: 23357-66.
24
van ’t Veer C,
Mann KG.
Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997; 272: 4367-77.
27
Bajaj SP,
Rapaport SI,
Prodanos C.
A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
28
Katzmann JA,
Nesheim ME,
Hibbard LS,
Mann KG.
Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 162-6.
29
Griffith MJ,
Noyes CM,
Church FC.
Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-25.
32
Nesheim ME,
Tracy RP,
Mann KG.
“Clotspeed”, a mathematical simulation of the functional properties of prothrombinase. J Biol Chem 1984; 259: 1447-53.
33
Rosing J,
Tans G,
Govers-Riemslag JWP,
Zwaal RFA,
Hemker HC.
The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
34
van Dieijen G,
Tans G,
Rosing J,
Hemker HC.
The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-42.
38
Panella TJ,
Peters W,
White JG,
Hannun YA,
Greenberg CS.
Platelets acquire a secretion defect after high-dose chemotherapy. Cancer 1990; 65: 1711-6.
41
Roy AJ,
Jaffe N,
Djerassi I.
Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion 1973; 13: 283-90.
47
Miletich JP,
Kane WH,
Hofmann SL,
Stanford N,
Majerus PW.
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood 1979; 54: 1015-22.
51
Monkovic DD,
Tracy PB.
Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132-40.